Menu Search
Equities

Zimmer Biomet Holdings Inc

ZBH:NYQ

Zimmer Biomet Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)106.34
  • Today's Change0.06 / 0.06%
  • Shares traded1.73m
  • 1 Year change-12.56%
  • Beta1.0378
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy5
Outperform5
Hold19
Sell2
Strong Sell0

Share price forecast in USD

The 25 analysts offering 12 month price targets for Zimmer Biomet Holdings Inc have a median target of 123.00, with a high estimate of 145.00 and a low estimate of 107.00. The median estimate represents a 15.67% increase from the last price of 106.34.
High36.4%145.00
Med15.7%123.00
Low0.6%107.00

Dividends in USD

In 2023, Zimmer Biomet Holdings Inc reported a dividend of 0.96 USD, equaling last years dividend. The 9 analysts covering the company expect dividends of 1.00 USD for the upcoming fiscal year, an increase of 3.85%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Aug 07, 2024, Zimmer Biomet Holdings Inc reported 2nd quarter 2024 earnings of 2.01 per share. This result was in line with the consensus of the 26 analysts following the company and exceeded last year's 2nd quarter results by 10.44%.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+3.95%
Zimmer Biomet Holdings Inc reported annual 2023 earnings of 7.55 per share on Feb 08, 2024.
Average growth rate+1.27%
More ▼

Revenue history & estimates in USD

Zimmer Biomet Holdings, Inc. had 2nd quarter 2024 revenues of 1.94bn. This bettered the 1.94bn consensus of the 24 analysts covering the company. This was 6.06% above the prior year's 2nd quarter results.
Average growth rate+1.15%
Zimmer Biomet Holdings, Inc. had revenues for the full year 2023 of 7.39bn. This was 6.55% above the prior year's results.
Average growth rate-1.33%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.